Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis [clinicaltrials_resource:NCT00251004/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis [clinicaltrials_resource:NCT00251004/outcome/1]
Bio2RDF identifier
NCT00251004/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00251004/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Intention to treat (ITT) population.
Intention-to-treat (ITT) population
Intention-to-treat (ITT) population.
Intention-to-treat population
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
at 12 months
type [clinicaltrials_vocabulary:type]
alternate
Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis
@en
identifier
clinicaltrials_resource:NCT00251004/outcome/1
title
The primary efficacy endpoint ...... ysis as well as re-transplant.
@en
type
label
Number of Participants With Co ...... esource:NCT00251004/outcome/1]
@en